Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Giant Biogene Holding Co. Ltd. ( (HK:2367) ) is now available.
Giant Biogene Holding Co., Ltd announced an increase in shareholding by its controlling shareholder, Juzi Holding Co., Ltd, as a demonstration of confidence in the company’s future development. Juzi Holding has purchased 2,006,600 shares, amounting to approximately HK$105.6 million, raising its total ownership to 54.45% of the company’s issued shares. This move is intended to promote sustainable growth and protect public investor interests, with potential further share purchases depending on market conditions.
The most recent analyst rating on (HK:2367) stock is a Buy with a HK$70.00 price target. To see the full list of analyst forecasts on Giant Biogene Holding Co. Ltd. stock, see the HK:2367 Stock Forecast page.
More about Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd is a company incorporated in the Cayman Islands, focusing on the biotechnology industry. It is primarily involved in the development and commercialization of biotechnological products and services.
Average Trading Volume: 11,637,344
Technical Sentiment Signal: Buy
Current Market Cap: HK$66.84B
See more insights into 2367 stock on TipRanks’ Stock Analysis page.